Litcius/Paper detail

Interleukins and Ischemic Stroke

Hua Zhu, Siping Hu, Yuntao Li, Yao Sun, Xiaoxing Xiong, Xinyao Hu, Junjing Chen, Sheng Qiu

2022Frontiers in Immunology372 citationsDOIOpen Access PDF

Abstract

Ischemic stroke after cerebral artery occlusion is one of the major causes of chronic disability worldwide. Interleukins (ILs) play a bidirectional role in ischemic stroke through information transmission, activation and regulation of immune cells, mediating the activation, multiplication and differentiation of T and B cells and in the inflammatory reaction. Crosstalk between different ILs in different immune cells also impact the outcome of ischemic stroke. This overview is aimed to roughly discuss the multiple roles of ILs after ischemic stroke. The roles of IL-1, IL-2, IL-4, IL-5, IL-6, IL-8, IL-9, IL-10, IL-12, IL-13, IL-15, IL-16, IL-17, IL-18, IL-19, IL-21, IL-22, IL-23, IL-32, IL-33, IL-34, IL-37, and IL-38 in ischemic stroke were discussed in this review.

Topics & Concepts

Ischemic strokeMedicineStroke (engine)Immune systemInterleukinCrosstalkInterleukin 17ImmunologyCytokineIschemiaInternal medicineOpticsMechanical engineeringEngineeringPhysicsNeuroinflammation and Neurodegeneration MechanismsPharmacological Effects of Natural CompoundsTryptophan and brain disorders
Interleukins and Ischemic Stroke | Litcius